SCHEMBL27579014

SCHEMBL27579014

Cc1cc(Nc2nc(-c3sccc3Br)nc3ccccc23)[nH]n1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 4/20 0.44
▸ AURKA O14965 4/20 0.44
▸ GSK3A P49840 3/20 0.44
▸ SRC P12931 2/20 0.44
▸ AURKB Q96GD4 2/20 0.44
▸ EIF2AK2 P19525 1/20 0.44
▸ ABCG2 Q9UNQ0 6/20 0.40
▸ TGFBR1 P36897 4/20 0.40
▸ PDE5A O76074 2/20 0.40
▸ ABCB1 P08183 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27596709 0.82 GSK3B (0.45) GSK3BAURKAGSK3ASRCAURKB
SCHEMBL27577273 0.81 PDE5A (0.62) GSK3BAURKAGSK3ASRCAURKB
SCHEMBL786402 0.81 GSK3B (0.65) GSK3BAURKAGSK3ASRCAURKB
SCHEMBL786191 0.80 ABCG2 (0.58) GSK3BAURKAGSK3ASRCAURKB
SCHEMBL786318 0.78 GSK3B (0.62) GSK3BAURKAGSK3ASRCAURKB
SCHEMBL786434 0.78 GSK3B (0.51) GSK3BAURKAGSK3ASRCAURKB
SCHEMBL27579056 0.78 ABCG2 (0.43) GSK3BAURKAGSK3ASRCAURKB
SCHEMBL786854 0.78 CYP1A2 (0.60) GSK3BAURKAGSK3ASRCAURKB
SCHEMBL786683 0.78 GSK3B (0.49) GSK3BAURKAGSK3ASRCAURKB
SCHEMBL27578992 0.77 PDE5A (0.45) GSK3BAURKAGSK3ASRCAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100408573-C Pyrazole compounds useful as protein kinase inhibitors VERTEX PHARMA (US) 2008-08-06 — — CN claimed
CN-1486311-A Pyrazole compounds useful as protein kinase inhibitors ��̩��˹ҩ��ɷ����޹�˾ 2004-03-31 — — CN claimed
Send feedback